CAMPYLOBACTER JEJUNI AND HELICOBACTER PYLORI PRACTICAL SIGNIFICANCE, MODERN LABORATORY DIAGNOSIS
Keywords:
Helicobacter pylori, pathogenesis, clinical manifestations, laboratory diagnosis, microaerophilic bacteria, gastroenterological infections, urease test, stool antigen test, antibiotic resistance.Abstract
This article analyzes the mechanisms of pathogenesis, clinical manifestations, and laboratory diagnostics of infections caused by Campylobacter jejuni and Helicobacter pylori. Campylobacter infection is mainly transmitted through food and presents with acute intestinal inflammation, diarrhea, abdominal pain, and fever. In some cases, post-infectious autoimmune complications affecting the nervous system may occur. Helicobacter pylori can persist in the gastric mucosa for a long time, contributing to chronic gastritis, peptic ulcer disease, and malignant changes. The article explains in simple terms the mechanisms of bacterial adhesion, tissue invasion, and inflammation induction. Diagnostic methods such as microaerophilic culture, urease and breath tests, stool antigen detection, and molecular techniques are comparatively evaluated. The growing problem of antibiotic resistance and the importance of modern molecular approaches for early diagnosis and appropriate treatment selection are also highlighted.
References
Alobaidy HAK, Ayvaz A, Sağiroğlu P, Atalay MA. Diagnosis of Campylobacter spp. Isolates and Their Antimicrobial Susceptibility Patterns. Indian J Microbiol. 2024 Sep;64(3):1000-1008. doi: 10.1007/s12088-024-01199-5. Epub 2024 Feb 13. PMID: 39282160; PMCID: PMC11399354
Burnham, P.M., Hendrixson, D.R. Campylobacter jejuni: collective components promoting a successful enteric lifestyle. Nat Rev Microbiol 16, 551–565 (2018). https://doi.org/10.1038/s41579-018-0037-9
Cabrera C, Torres J, Serrano CA, Gallardo P, Orellana V, George S, O'Ryan M, Lucero Y. Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008-2023): A Systematic Review. Helicobacter. 2024 Jul-Aug;29(4):e13101. doi: 10.1111/hel.13101. Erratum in: Helicobacter. 2024 Sep-Oct;29(5):e13145.
Chen S, Chen Z, Cui J, McCrary ML, Song H, Mobashery S, Chang M, Gu Z. Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice. eNeuro. 2018 Jun 27;5(3):ENEURO.0391-17.2018. doi: 10.1523/ENEURO.0391-17.2018. PMID: 29963617; PMCID: PMC6021166.
Cho JH, Jin SY. Diagnosis and treatment of Helicobacter pylori infection: past, present, and future. Future Microbiol. 2025 Sep;20(13):913-929. doi: 10.1080/17460913.2025.2568326. Epub 2025 Oct 5. PMID: 41047664; PMCID: PMC12645878.
Contreras M, Mujica H and García-Amado MA (2024) Molecular tools of antibiotic resistance for Helicobacter pylori: an overview in Latin America. Front. Gastroenterol. 3:1410816. doi: 10.3389/fgstr.2024.1410816
Derakhshan-sefidi, M., Bakhshi, B., Hamidi, F. et al. Prevalence and antimicrobial resistance patterns of Campylobacter spp. Causing human gastroenteritis in Iran (2000–2025): a systematic review and meta-analysis. BMC Infect Dis 25, 1742 (2025).
Editorial Board. J Virol. 2020 Dec 9;95(1):masthead-95-1. doi: 10.1128/JVI.masthead.95-1. PMCID: PMC7737749.
Elbaiomy, R.G., Luo, X., Guo, R. et al. Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective. Gut Pathog 17, 35 (2025).
Gentilini F, Turba ME, Pasquali F, Mion D, Romagnoli N, Zambon E, Terni D, Peirano G, Pitout JDD, Parisi A, Sambri V and Zanoni RG (2018) Hospitalized Pets as a Source of Carbapenem-Resistance. Front. Microbiol. 9:2872. doi: 10.3389/fmicb.2018.02872
Hasanuzzaman M, Bang CS, Gong EJ. Antibiotic Resistance of Helicobacter pylori: Mechanisms and Clinical Implications. J Korean Med Sci. 2024 Jan 29;39(4):e44. doi: 10.3346/jkms.2024.39.e44. PMID: 38288543; PMCID: PMC10825452.
Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev. 2015 Jul;28(3):687-720. doi: 10.1128/CMR.00006-15. PMID: 26062576; PMCID: PMC4462680.
Kordyum EL. Gravisensitivity of plant cells: status and prospects. J Gravit Physiol. 2002 Jul;9(1):P219-20. PMID: 15002555.
Li Z, Cai H, Xu B, Dong Q, Jia K, Lin Z, Wang X, Liu Y, Qin X. Prevalence, antibiotic resistance, resistance and virulence determinants of Campylobacter jejuni in China: A systematic review and meta-analysis. One Health. 2025 Feb 10;20:100990. doi: 10.1016/j.onehlt.2025.100990. PMID: 40027923; PMCID: PMC11871471.
Malfertheiner, P., Camargo, M.C., El-Omar, E. et al. Helicobacter pylori infection. Nat Rev Dis Primers 9, 19 (2023).
Maurin M, Raoult D. Q fever. Clin Microbiol Rev. 1999 Oct;12(4):518-53. doi: 10.1128/CMR.12.4.518. PMID: 10515901; PMCID: PMC88923.
Pittie, G.; Laurent, T.; Radermacher, J.; Herens, S.; Boeras, A.; Ho, G. Detection by Real-Time PCR of Helicobacter pylori and Clarithromycin Resistance Compared to Histology on Gastric Biopsies. Microorganisms 2024, 12, 2192.
Shao, Y., Lin, Y., Fang, Z. et al. Analysis of Helicobacter pylori resistance in patients with different gastric diseases. Sci Rep 14, 4912 (2024).
Sharafutdinov I, Linz B, Tegtmeyer N and Backert S (2025) Therapeutic and protective approaches to combat Campylobacter jejuni infections. Front. Pharmacol. 16:1572616. doi: 10.3389/fphar.2025.1572616
Sinkovics JG, Horvath JC. Self-defense of human sarcoma cells against cytolytic lymphoid cells of their host. Eur J Microbiol Immunol (Bp). 2021 Jul 5;11(2):44-49. doi: 10.1556/1886.2021.11111. PMID: 34218219; PMCID: PMC8287976.
Tao, W., Ma, W., Zhao, G. et al. Characterization of antibiotic resistance and biofilm formation in clinical Helicobacter pylori isolates from Ningxia, China. Sci Rep 15, 45439 (2025).
Tshibangu-Kabamba, E., Yamaoka, Y. Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications. Nat Rev Gastroenterol Hepatol 18, 613–629 (2021
Vinette, K.M., Gibney, K.M., Proujansky, R. et al. Comparison of PCR and clinical laboratory tests for diagnosing H. pylori infection in pediatric patients. BMC Microbiol 4, 5 (2004).
Yu Y, Xue J, Lin F, Liu D, Zhang W, Ru S, Jiang F. Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta-Analysis. Helicobacter. 2024 May-Jun;29(3):e13103. doi: 10.1111/hel.13103. PMID: 38898622.
Yu Y, Xue J, Lin F, Liu D, Zhang W, Ru S, Jiang F. Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta-Analysis. Helicobacter. 2024 May-Jun;29(3):e13103. doi: 10.1111/hel.13103. PMID: 38898622.
McNulty CAM. The first 5 years of Helicobacter pylori research—With an emphasis on the United Kingdom. Helicobacter. 2023;28:e12982. doi:10.1111/hel.12982






Azerbaijan
Türkiye
Uzbekistan
Kazakhstan
Turkmenistan
Kyrgyzstan
Republic of Korea
Japan
India
United States of America
Kosovo